articleJournal of the American Academy of DermatologyDec 3, 2007Closed access

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

AMAlan MenterSKStephen K. TyringKBKenneth B. GordonABAlexa B. KimballCLCraig L. Leonardi

The University of Texas Southwestern Medical Center · The University of Texas Health Science Center at Houston · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

880
total citations
FWCI
14.25
Percentile
100%
References
17
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • Medicine
  • Adalimumab
  • Psoriasis
  • Randomized controlled trial
  • Dermatology
  • Physical therapy
  • Internal medicine
  • Tumor necrosis factor alpha
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.